![](https://ml.globenewswire.com/media/3ae2de11-e705-444d-b11c-0010af38d2d9/small/cannara-ticker-logo-black-jan-2024-png.png)
Cannara Biotech Reports Q3 2024 Financial Results
Gross cannabis revenues before excise taxes increased to $26.2 million in Q3 2024 from $20.6 million in Q3 2023, a $5.6 million or 27.6%, increase. Total revenues, net of excise taxes, increased to $19.5 million in Q3 2024 from $15.9 million in Q3 2023, a …